In perimenopause the scale holds steady while body composition does not
In short
Reviewing 56 studies published between 2000 and 2026, perimenopause produces increased visceral fat, loss of lean mass, reduced fat oxidation and impaired metabolic flexibility — frequently without a significant change in body weight. Because the scale looks normal, the shift is often recognized late in clinical settings. The interventions with the strongest evidence for preserving muscle and improving insulin sensitivity were resistance training and adherence to a Mediterranean diet.
Perimenopause is the span of years before menstruation stops entirely, during which estradiol fluctuates and declines. This review pulled 56 studies published between 2000 and 2026 from PubMed, Scopus, Web of Science and SciELO to describe why this period functions as a window of metabolic vulnerability.
The central point is that body weight is misleading here. These changes progress without a large weight gain, so neither the woman nor her clinician catches them early. Fat redistributing toward the viscera while lean mass falls, at a stable weight, is the signature pattern of this stage.
What exactly changes?
The review reported four consistent shifts: increased visceral fat, loss of lean mass, reduced fat oxidation, and impaired metabolic flexibility. The last one is the body's ability to switch its primary fuel between carbohydrate and fat as circumstances demand. When it degrades, the same meals and the same workouts produce different responses than they used to.
Why does falling estrogen do this?
Declining estrogen drives adipose redistribution, muscle dysfunction, hepatic insulin resistance and chronic low-grade inflammation together. Stacked, those four raise the risk of metabolic syndrome, type 2 diabetes and cardiovascular events. While menopause is often discussed purely as a symptom burden, a separate metabolic clock is running underneath it.
What worked?
Two things carried real evidentiary weight in this review: resistance training and adherence to a Mediterranean diet. That combination showed strong potential to preserve muscle, improve insulin sensitivity and lower inflammation. Note that resistance training, not aerobic work, is named first. If what is being lost is lean mass, the stimulus has to defend lean mass.
So what should you track?
Not weight. If the changes progress at a stable weight, the scale is the least sensitive instrument available in this window. What does respond is the weight on the bar — when lean mass falls, squat, bench and deadlift register it first. A score built from a Big 3 total relative to bodyweight will fall when strength falls even though bodyweight has not moved, which makes it an earlier alarm than the scale. The post-menopausal picture continues in the lipid shift of the first year and muscle-bone crosstalk.
This is a narrative review and it includes some animal-model studies. It did not pool effect sizes the way a meta-analysis would, so the resistance training and diet recommendations should be read as direction rather than dose. Symptoms and lab values are a matter for a clinician, not an article.
Frequently asked questions
If my weight has not changed during perimenopause, is there anything to manage?
Yes. Across the 56 studies in this review, visceral fat gain and lean mass loss progressed without significant weight change. Having a normal number on the scale is precisely why the shift tends to be recognized late.
What kind of exercise is most effective in perimenopause?
Resistance training. In this review the interventions showing the strongest potential to preserve muscle, improve insulin sensitivity and reduce inflammation were resistance training and Mediterranean diet adherence. Since lean mass is what is being lost, the stimulus that defends it comes first.
What does impaired metabolic flexibility mean?
It means the body has become worse at switching its primary fuel between carbohydrate and fat as demands change. When that ability declines, identical meals and identical workouts produce different metabolic responses than before.
What risks rise as estrogen declines?
Falling estrogen drives fat redistribution toward the viscera, muscle dysfunction, hepatic insulin resistance and chronic low-grade inflammation. Together these raise the risk of metabolic syndrome, type 2 diabetes and cardiovascular events.
Source: PubMed